Table of Content



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hepatitis A - Overview
Hepatitis A - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hepatitis A - Therapeutics Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Hepatitis A - Companies Involved in Therapeutics Development
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
Boryung Pharmaceutical Co Ltd
Cadila Healthcare Ltd
Chi tiol Pharmaceutical Group Corp
Et Biotech Srl
Indian Immunologicals Ltd
Liaoning Cheng Da Biotechnology Co Ltd
Novo Medi Sciences Pvt Ltd
Sinovac Biotech Ltd
Hepatitis A - Drug Profiles
BR-8003 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A + hepatitis B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A [strain (RGSB)] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hepatitis A - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures



Number of Products under Development for Hepatitis A, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables



Number of Products under Development for Hepatitis A, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Hepatitis A - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2020
Hepatitis A - Pipeline by Biological E Ltd, H2 2020
Hepatitis A - Pipeline by Boryung Pharmaceutical Co Ltd, H2 2020
Hepatitis A - Pipeline by Cadila Healthcare Ltd, H2 2020
Hepatitis A - Pipeline by China National Pharmaceutical Group Corp, H2 2020
Hepatitis A - Pipeline by Etna Biotech Srl, H2 2020
Hepatitis A - Pipeline by Indian Immunologicals Ltd, H2 2020
Hepatitis A - Pipeline by Liaoning Cheng Da Biotechnology Co Ltd, H2 2020
Hepatitis A - Pipeline by Novo Medi Sciences Pvt Ltd, H2 2020
Hepatitis A - Pipeline by Sinovac Biotech Ltd, H2 2020
Hepatitis A - Dormant Projects, H2 2020